ASX Announcement

29th March 2022

Perth, Western Australia – Australian medical technology company, Artrya Limited (ASX: AYA, Artrya or the Company) creator of the AI-based solution, Artrya Salix, that supports physicians in the diagnosis of coronary artery disease, today announces the formation of the Company’s American subsidiary, Artrya USA Inc. (Artrya USA) with its headquarters in Los Angeles, California. Ted Schwab and Jory Tremblay have been employed as Co-CEOs of Artrya USA and will head up the Company’s entry into the US market.

Read the full Media Release.